Basilea gibt Clinical Supply Agreement für geplante FIDES-03-Studie mit Derazantinib bei Magenkrebs bekannt

NEXT STORY
Orion publishes Financial Statement Release for 2019 on 5 February 2020
PREV STORY
Persbericht Biocartis Group: Biocartis gaat master samenwerkingsovereenkomst aan met AstraZeneca en start EGFR vloeibare biopsiestudie
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helix BioPharma Corp. Announces Fiscal Third Quarter 2018 Results

RICHMOND HILL, Ontario, June 12, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) ...

author_avatar
NASDAQ Market News

Aptose Reports Results for the Third Quarter Ended September 30, 2018

Conference call is scheduled for tomorrow, Wednesday, November 7th at 8:00 AM ET SAN ...

author_avatar
NASDAQ Market News

Onxeo Announces Top-Line Results from ReLive Phase III Study of Livatag® in Advanced Hepatocellular Carcinoma

PARIS, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Paris:ONXEO) (NASDAQ Copenhagen:ONXEO), (“Onxeo” ...

author_avatar
NASDAQ Market News